1
|
Jodar M, Barral Y, Leiva M, Castillo J, Barrio R, Agustí I, Borràs A, Carrillo P, Matheu R, Ferreti R, Herrero J, Reimundo P, Navero-Castillejos J, Casals G, Guimerà M, Corral JM, Martinez M, Carbonell M, Bassas L, Manau D, Oliva R. Reversible effects of the SARS-CoV-2 on semen parameters. Syst Biol Reprod Med 2024; 70:261-271. [PMID: 39217625 DOI: 10.1080/19396368.2024.2390514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 08/02/2024] [Accepted: 08/05/2024] [Indexed: 09/04/2024]
Abstract
Despite that the SARS-CoV-2 pandemic has been controlled, it has affected a large proportion of the population, raising some concerns about potential sequelae in men at reproductive age. To contribute to the clarification of this issue, we performed a retrospective study comparing semen parameters values before and after confirmed SARS-CoV-2 infection in a large cohort of infertile men, compared to a control group that did not undergo SARS-CoV-2 infection. Wilcoxon test on paired samples and general linear regression model showed that SARS-CoV-2 infection has a detrimental effect on semen volume values (p < 0.005). However, semen volume seems to be significantly lower only during the first spermatogenic cycle after SARS-COV-2 infection (p < 0.005) and mainly in unvaccinated patients (p < 0.05). In addition, we detected alterations in progressive motility in patients infected with the alpha SARS-COV-2 strain (p < 0.05). In conclusion, our results show that although SARS-CoV-2 has a small effect on semen volume and sperm motility in infertile men, depending on the infectious strain or vaccination status, pre-infection values of semen parameters appear to be restored over one spermatogenic cycle after infection.
Collapse
Affiliation(s)
- Meritxell Jodar
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Biochemistry and Molecular Genetics Service (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Yasmina Barral
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Marina Leiva
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
| | - Judit Castillo
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
| | - Ruth Barrio
- Catalan Transplant Organization (OCATT), Catalan Health Service (CatSalut), Barcelona, Spain
| | - Inés Agustí
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Aina Borràs
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Pilar Carrillo
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Roger Matheu
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Clinic Institute of Urology and Nephrology, Hospital Clínic de Barcelona, Barcelona, Spain
| | - Raquel Ferreti
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Julio Herrero
- Maternal-Foetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Pilar Reimundo
- Laboratory of Assisted Reproduction and Andrology, Area of Clinical Biochemistry, Vall d'Hebron Clinical Laboratories, Vall d'Hebron University Hospital, Barcelona, Spain
| | - Jessica Navero-Castillejos
- Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
| | - Gemma Casals
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Gynecological Endocrinology and Human Reproduction Group, Barcelona, Spain
| | - Marta Guimerà
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Juan Manuel Corral
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Clinic Institute of Urology and Nephrology, Hospital Clínic de Barcelona, Barcelona, Spain
| | - Mikel Martinez
- Microbiology (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| | - Melchor Carbonell
- Maternal-Foetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Lluís Bassas
- Laboratory of Seminology and Embryology, Andrology Service, Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau- Fundació Puigvert, Barcelona, Spain
| | - Dolors Manau
- Clinic Institute of Gynaecology, Obstetrics and Neonatology (ICGON), Hospital Clínic de Barcelona, Barcelona, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Gynecological Endocrinology and Human Reproduction Group, Barcelona, Spain
| | - Rafael Oliva
- Molecular Biology of Reproduction and Development Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundació de Recerca Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain
- Biochemistry and Molecular Genetics Service (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| |
Collapse
|
2
|
Dabizzi S, Maggi M, Torcia MG. Update on known and emergent viruses affecting human male genital tract and fertility. Basic Clin Androl 2024; 34:6. [PMID: 38486154 PMCID: PMC10941432 DOI: 10.1186/s12610-024-00222-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Accepted: 02/28/2024] [Indexed: 03/17/2024] Open
Abstract
Many viruses infect the male genital tract with harmful consequences at individual and population levels. In fact, viral infections may induce damage to different organs of the male genital tract (MGT), therefore compromising male fertility. The oxidative stress, induced during viral-mediated local and systemic inflammation, is responsible for testicular damage, compromising germinal and endocrine cell functions. A reduction in sperm count, motility, number of normal sperm and an increase in DNA fragmentation are all common findings in the course of viral infections that, however, generally regress after infection clearance. In some cases, however, viral shedding persists for a long time leading to unexpected sexual transmission, even after the disappearance of the viral load from the blood.The recent outbreak of Zika and Ebola Virus evidenced how the MGT could represent a reservoir of dangerous emergent viruses and how new modalities of surveillance of survivors are strongly needed to limit viral transmission among the general population.Here we reviewed the evidence concerning the presence of relevant viruses, including emergent and re-emergent, on the male genital tract, their route of entry, their adverse effects on male fertility and the pattern of viral shedding in the semen.We also described laboratory strategies to reduce the risk of horizontal or vertical cross-infection in serodiscordant couples undergoing assisted reproductive technologies.
Collapse
Affiliation(s)
- Sara Dabizzi
- Andrology, Women's Endocrinology and Gender Incongruence Unit, Center for the Prevention, Diagnosis and Treatment of Infertility, Azienda Ospedaliera Universitaria Careggi Hospital, Florence, Italy.
| | - Mario Maggi
- Endocrinology Unit, Azienda Ospedaliera Universitaria Careggi Hospital, Florence, Italy.
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale G. Pieraccini 6, Florence, Italy.
| | - Maria Gabriella Torcia
- Andrology, Women's Endocrinology and Gender Incongruence Unit, Center for the Prevention, Diagnosis and Treatment of Infertility, Azienda Ospedaliera Universitaria Careggi Hospital, Florence, Italy
- Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy
| |
Collapse
|